These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

477 related items for PubMed ID: 24521072

  • 1. Mycophenolate mofetil and enteric-coated mycophenolate sodium in the treatment of pemphigus vulgaris and pemphigus foliaceus.
    Doukaki S, Platamone A, Alaimo R, Bongiorno MR.
    J Dermatolog Treat; 2015 Feb; 26(1):67-72. PubMed ID: 24521072
    [Abstract] [Full Text] [Related]

  • 2. Treatment of pemphigus vulgaris with mycophenolate mofetil as a steroid-sparing agent.
    Esmaili N, Chams-Davatchi C, Valikhani M, Farshidfar F, Parvaneh N, Tamizifar B.
    Eur J Dermatol; 2008 Feb; 18(2):159-64. PubMed ID: 18424375
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Mycophenolate mofetil as an adjuvant therapy for classic and endemic pemphigus foliaceus.
    Kawashita MY, Tsai K, Aoki V, Santi CG, Maruta CW, Rivitti E.
    J Dermatol; 2005 Jul; 32(7):574-80. PubMed ID: 16335874
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of pemphigus.
    Beissert S, Werfel T, Frieling U, Böhm M, Sticherling M, Stadler R, Zillikens D, Rzany B, Hunzelmann N, Meurer M, Gollnick H, Ruzicka T, Pillekamp H, Junghans V, Luger TA.
    Arch Dermatol; 2006 Nov; 142(11):1447-54. PubMed ID: 17116835
    [Abstract] [Full Text] [Related]

  • 9. Successful treatment with mycophenolate mofetil of four Japanese patients with pemphigus vulgaris.
    Koga H, Ishii N, Hamada T, Karashima T, Nakama T, Yasumoto S, Hashimoto T.
    Eur J Dermatol; 2010 Nov; 20(4):472-5. PubMed ID: 20406724
    [Abstract] [Full Text] [Related]

  • 10. An evaluation of the usefulness of mycophenolate mofetil in pemphigus.
    Powell AM, Albert S, Al Fares S, Harman KE, Setterfield J, Bhogal B, Black MM.
    Br J Dermatol; 2003 Jul; 149(1):138-45. PubMed ID: 12890207
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Mycophenolate mofetil as a first-line steroid-sparing agent in the treatment of pemphigus vulgaris.
    Vyas N, Patel NS, Cohen GF.
    J Drugs Dermatol; 2013 Feb; 12(2):210-6. PubMed ID: 23377396
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetic evaluation of mycophenolate mofetil for pemphigus.
    Doukaki S, Pistone G, Aricò M, Bongiorno MR.
    Expert Opin Drug Metab Toxicol; 2011 Feb; 7(2):237-44. PubMed ID: 21192770
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Pemphigus foliaceus successfully treated with mycophenolate mofetil as a steroid-sparing agent.
    Katz KH, Marks JG, Helm KF.
    J Am Acad Dermatol; 2000 Mar; 42(3):514-5. PubMed ID: 10688729
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Mycophenolate mofetil versus enteric-coated mycophenolate sodium: a large, single-center comparison of dose adjustments and outcomes in kidney transplant recipients.
    Sollinger HW, Sundberg AK, Leverson G, Voss BJ, Pirsch JD.
    Transplantation; 2010 Feb 27; 89(4):446-51. PubMed ID: 20177347
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.